Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001704292-26-000030
Filing Date
2026-04-28
Accepted
2026-04-28 07:16:37
Documents
21
Period of Report
2026-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A zlab-20260428.htm   iXBRL DEF 14A 1244179
3 zlab-20260428_g1.jpg GRAPHIC 14140
4 zlab-20260428_g2.jpg GRAPHIC 4107
5 zlab-20260428_g3.jpg GRAPHIC 3172
6 zlab-20260428_g4.jpg GRAPHIC 267878
7 zlab-20260428_g5.jpg GRAPHIC 74219
8 zlab-20260428_g6.jpg GRAPHIC 56317
9 zlab-20260428_g7.jpg GRAPHIC 58276
10 zlab-20260428_g8.jpg GRAPHIC 458051
11 zlab-20260428_g9.jpg GRAPHIC 389584
  Complete submission text file 0001704292-26-000030.txt   5297364

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zlab-20260428.xsd EX-101.SCH 912
24 EXTRACTED XBRL INSTANCE DOCUMENT zlab-20260428_htm.xml XML 231433
Mailing Address 899 HALEI ROAD BUILDING B, PUDONG SHANGHAI China
Business Address 899 HALEI ROAD BUILDING B, PUDONG SHANGHAI China 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38205 | Film No.: 26903114
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)